Bioactivity Assay Development Consultant Support Services

The National Institutes of Health National Institute on Drug Abuse seeks to retain senior-level consultants with expertise in bioactivity assay development to provide leadership and technical guidance to the Blueprint Neurotherapeutics Program and other NIH neuroscience-focused drug development programs. Consultants will advise on strategic planning and management of programs, collaborate on study design, and serve as a resource on assay requirements and logistics to support drug development initiatives from preclinical through initial clinical stages. Proposals will be evaluated based on personnel qualifications, technical approach, communication skills, price, and past performance, with a submission deadline of August 20, 2021.

This is a total small business set-aside with a size standard of $15 million. The anticipated contract type is labor-hour with a one-year base period of performance starting September 27, 2021 and two one-year option periods. Key details include an estimated 20 hours of support annually for the base period with 800 optional hours, and up to $1,200 per year for travel on an as-needed basis. The primary place of performance is the contractor's site, with occasional work at government facilities in Bethesda, Maryland.